During the past decade, Wielkopolskie Centrum Onkologii conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wielkopolskie Centrum Onkologii" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Institut de Recherches Internationales Servier" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wielkopolskie Centrum Onkologii" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Wielkopolskie Centrum Onkologii" are "Breast Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Cervical Cancer" (3 trials), "Metastatic Colorectal Cancer" (3 trials) and "Epithelial Ovarian Cancer" (2 trials). Many other conditions were trialed in "Wielkopolskie Centrum Onkologii" in a lesser frequency.

Most popular intervention types in "Wielkopolskie Centrum Onkologii" are "Drug" (28 trials), "Biological" (6 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (6 trials), "Atezolizumab" (4 trials), "Placebo" (4 trials), "Carboplatin" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wielkopolskie Centrum Onkologii" are 21 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wielkopolskie Centrum Onkologii". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Wielkopolskie Centrum Onkologii, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Wielkopolskie Centrum Onkologii, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Wielkopolskie Centrum Onkologii has several departments that took part in Clinical trials: "The Great Poland Cancer Centre" - 11 trials, "Wielkopolskie Centrum Onkologii; Oddzial Chemioterapii" - 4 trials